APA

Castella B., Foglietta M., Sciancalepore P., Rigoni M., Coscia M., Griggio V., Vitale C., Ferracini R., Saraci E., Omedé P., Riganti C., Palumbo A., Boccadoro M. & Massaia M. (2015). Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma. : Oncoimmunology.

Chicago

Castella Barbara, Foglietta Myriam, Sciancalepore Patrizia, Rigoni Micol, Coscia Marta, Griggio Valentina, Vitale Candida, Ferracini Riccardo, Saraci Elona, Omedé Paola, Riganti Chiara, Palumbo Antonio, Boccadoro Mario and Massaia Massimo. 2015. Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma. : Oncoimmunology.

Harvard

Castella B., Foglietta M., Sciancalepore P., Rigoni M., Coscia M., Griggio V., Vitale C., Ferracini R., Saraci E., Omedé P., Riganti C., Palumbo A., Boccadoro M. and Massaia M. (2015). Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma. : Oncoimmunology.

MLA

Castella Barbara, Foglietta Myriam, Sciancalepore Patrizia, Rigoni Micol, Coscia Marta, Griggio Valentina, Vitale Candida, Ferracini Riccardo, Saraci Elona, Omedé Paola, Riganti Chiara, Palumbo Antonio, Boccadoro Mario and Massaia Massimo. Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma. : Oncoimmunology. 2015.